Boston Scientific leads the way with master research agreement with U. Minn.
Boston Scientific is the 1st to sign a master research agreement under the Minnesota Innovation Partnerships, establishing streamlined standards for research grants, intellectual property rights, liability and more.
Medical device company Boston Scientific (NYSE:BSX) was the 1st to sign up for a master research agreement with the University of Minnesota under the school's Minnesota Innovation Partnerships initiative, which aims to streamline industry-funded research projects.
The MN-IP initiative represents the university's new management of intellectual properly that arises from industry-university partnerships, and the master agreement aims to make concerns about liability, publication and other standards painless and consistent.
Medtech giant Boston Scientific plans to partner with U-Minn. on programs spanning everything from talent recruitment and training to research, calling the MN-IP approach "a much more efficient and innovative way to approach a university partnership," Boston Scientific cardiac rhythm management vice president Randy Schiestl told the university.